SAFC’s approach to staying Flexible in a Changing Market – SAFC moves ahead with ADCs 

Keywords:

e-version image

Click HERE to download the PDF version

 

 



Pharmaceutical innovation is being redefined across the globe, and regulations for drug products are becoming more stringent every day. As a supplier to drug manufacturers big and small, SAFC, the custom manufacturing services business unit of Sigma-Aldrich, sees these changes as an opportunity to enhance our commitment to customers.

Total global spending on medicines is expected to exceed $1 trillion for the first time in 2014, and reach almost $1.2 trillion in 2017. This growth is diverse, shattering the “traditional” concept of pharmaceutical production. While many factors have contributed to the dynamic pharmaceutical landscape of today and the future, a few notable trends have acted as fundamental drivers of this change:

  • A shift in focus from blockbuster drugs to specialist care drugs ...
  • ...